Effects of milrinone for right ventricular failure after left ventricular assist device implantation

被引:0
作者
S. Kihara
Akihiko Kawai
Takuya Fukuda
Noboru Yamamoto
Shigeyuki Aomi
Hiroshi Nishida
Masahiro Endo
Hitoshi Koyanagi
机构
[1] Department of Cardiovascular Surgery,
[2] Heart Institute of Japan,undefined
[3] Tokyo Women’s Medical University,undefined
[4] 8-1 Kawada-cho,undefined
[5] Shinjuku-ku,undefined
[6] Tokyo 162-8666,undefined
[7] Japan,undefined
来源
Heart and Vessels | 2002年 / 16卷
关键词
Key words Left ventricular assist device; Right ventri-cular failure; Phosphodiesterase inhibitor; Pulmonary hypertension;
D O I
暂无
中图分类号
学科分类号
摘要
Right ventricular failure after left ventricular assist device implantation sometimes requires additional mechanical right ventricular support. The effectiveness of nitrates, prostaglandin, or nitric oxide inhalation in such cases has already been reported. However, there are few reports on the administration of phosphodiesterase inhibitor for right ventricular failure after left ventricular assist device implantation. We report two patients with right ventricular failure after left ventricular assist device implantation successfully treated with milrinone. Both had residual pulmonary hypertension due to high pulmonary vascular resistance after left ventricular assist device implantation. However, intravenous milrinone caused a significant reduction in pulmonary vascular resistance and an increase in left ventricular assist device flow. Milrinone acts as both an inotropic agent and a direct vasodilator, and thus may avoid the need for mechanical support for right ventricular failure due to residual pulmonary hypertension after left ventricular assist device implantation.
引用
收藏
页码:69 / 71
页数:2
相关论文
empty
未找到相关数据